CD20-negative Epstein–Barr virus-associated post-transplant lymphoproliferative disease refractory to rituximab in a patient with severe aplastic anemia

2011 ◽  
Vol 93 (6) ◽  
pp. 779-781 ◽  
Author(s):  
Hideki Muramatsu ◽  
Yoshiyuki Takahashi ◽  
Yoshie Shimoyama ◽  
Sayoko Doisaki ◽  
Nobuhiro Nishio ◽  
...  
Keyword(s):  
Aplastic Anemia ◽  
Epstein Barr Virus ◽  
Lymphoproliferative Disease ◽  
Severe Aplastic Anemia ◽  
Post Transplant ◽  
Barr Virus ◽  
Epstein Barr

Successful outcome of severe aplastic anemia following epstein-barr virus infection

1988 ◽  
Vol 28 (4) ◽  
pp. 273-275 ◽  
Author(s):  
Judy E. Grishaber ◽  
Kenneth L. McClain ◽  
Donald H. Mahoney ◽  
Donald J. Fernbach
Keyword(s):  
Virus Infection ◽  
Aplastic Anemia ◽  
Epstein Barr Virus ◽  
Severe Aplastic Anemia ◽  
Successful Outcome ◽  
Epstein Barr Virus Infection ◽  
Barr Virus ◽  
Epstein Barr ◽  
Barr Virus Infection

scholarly journals Successful treatment of severe aplastic anemia associated with human parvovirus B19 and Epstein-Barr virus in a healthy subject with allo-BMT

2001 ◽  
Vol 67 (4) ◽  
pp. 252-255 ◽  
Author(s):  
Kürşad Kaptan ◽  
Cengiz Beyan ◽  
Ali Uğur Ural ◽  
Celalettin Üstün ◽  
Türker Çetin ◽  
...  
Keyword(s):  
Healthy Subject ◽  
Aplastic Anemia ◽  
Successful Treatment ◽  
Epstein Barr Virus ◽  
Parvovirus B19 ◽  
Severe Aplastic Anemia ◽  
Human Parvovirus B19 ◽  
Barr Virus ◽  
Epstein Barr
Sign in / Sign up

Export Citation Format

Share Document